Remote Jobs at JenaValve Technology, Inc.
JenaValve Technology, Inc.
51 - 200 employees
Founded 2013
🏥 Healthcare
🔧 Hardware
🏭 Manufacturing
💰 $100M Series C - JenaValve Technology on 2022-08
Healthcare • Hardware • Manufacturing
JenaValve Technology, Inc. is a medical device company that developed the Trilogy Transcatheter Heart Valve System, the first and only FDA‑approved transcatheter aortic valve replacement (TAVR) specifically indicated to treat severe native tricuspid aortic valve regurgitation (AR). The Trilogy system uses locator technology to achieve commissural alignment and anchor the valve to native leaflets even when calcium is absent, and features a self‑expanding nitinol frame, porcine pericardial tissue with proprietary treatment, a purpose‑built delivery catheter, and an extended introducer sheath designed for stability and precise deployment. JenaValve markets the system for high‑risk surgical patients and supports its product with pivotal clinical study data demonstrating high technical success and low rates of embolization and residual AR.
Is on LinkedIn?
